As PI3K mutations and AKT hyper-activation frequently occurs in cancers, our results suggest that these alterations may also favor TRF1 stability, telomere protection and telomere maintenance, a hallmark of cancer cells [20]. The gene discussed is TERF1; the disease is cancer.